The group's principle activity is to provide contract development organization for the biopharmaceutical industry. The group accelerates and optimizes drug development and manufacturing programs for the client partners including global pharmaceutical and biotechnology companies and organizations in bio-defense. The group's services include formulation, analytical method development, stability services, process development, API manufacturing, and filling/finishing services. The group operates from United States.
